Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for ...
Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...
The FDA’s move to lift the hold on Zentalis Pharmaceuticals’ sole clinical-stage drug may have been good news for the biotech ...
Based on this feature of DBCM, we developed a new platelet functional assay that allows for the evaluation of the pharmacological effects of antiplatelet drugs. It is advantageous, as it detects the ...
C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...
They launched Prasugrel, a revolutionary new anti-platelet drug for the management of Acure Coronary Syndrome with PCT (Precutaneous Coronary Intervention) for the first time in India.During the ...
Platelet-Coupled IL-2 Cell Injection is under clinical development by Zcapsule Pharmaceuticals (Shaoxing) and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果